Regional Business Manager - Chicago
Intellia TherapeuticsAbout the role
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How You Will Achieve More:
We are seeking an exceptional Sales Representative to lead the commercial launch of our groundbreaking in vivo CRISPR therapy for hereditary angioedema (HAE). This role represents a career defining opportunity to pioneer the commercialization of the first-ever, single treatment gene editing therapy. The successful candidate will be responsible for introducing healthcare providers to the first-ever in vivo CRISPR therapy, requiring sophisticated scientific communication, complex stakeholder management, and exceptional execution within a highly competitive rare disease market.
This territory will cover Illinois, Indiana, and Wisconsin.
Responsibilities:
Territory Management & Account Development
- Territory Planning: Develop and execute comprehensive territory plans targeting immunologists, allergists, emergency medicine physicians, and specialized HAE treatment centers
- Account Prioritization: Identify and prioritize high-value accounts based on HAE patient volume, prescriber influence, and institutional capabilities
- Relationship Building: Establish trusted advisor relationships with key opinion leaders, clinical champions, and administrative decision-makers
- Pipeline Management: Maintain robust sales pipeline tracking opportunities from initial awareness through patient treatment completion
Scientific Education & Communication
- CRISPR Technology Education: Educate healthcare providers on in vivo CRISPR gene editing mechanisms, differentiating from ex vivo cell therapies and traditional treatments
- MOA Differentiation: Clearly articulate the unique mechanism of action compared to prophylactic treatments, complement inhibitors, and plasma-derived therapies
- Clinical Data Presentation: Present Phase III efficacy and safety data
- Technology Positioning: Address misconceptions about CRISPR safety and differentiate from previous gene therapy launches
- Disease Education: educate healthcare providers about unmet needs affecting disease management and treatment burden
Competitive Differentiation
- Competitive Intelligence: Maintain deep understanding of competitive landscape and emerging therapies
- Value Proposition Development: Articulate differentiated value propositions versus existing HAE treatments and other gene therapies
- Objection Handling: Proactively address concerns about CRISPR technology, permanent genetic modification, and single-treatment cost
- **Company Differentiation**: Position organization as innovative leader with s
Apply for this role
Generate a tailored application kit with a matched cover letter, interview prep, and CV highlights — in under 60 seconds.
Apply Now →Generate Application KitFree account required — sign up in 30s